265 related articles for article (PubMed ID: 20845618)
1. [Anaemia in chronic heart failure].
Hradec J
Vnitr Lek; 2010 Aug; 56(8):854-9. PubMed ID: 20845618
[TBL] [Abstract][Full Text] [Related]
2. [Diagnosis and treatment of anemia in heart failure patients].
Santilli G; Tarantini L; Baio P; Senni M
G Ital Cardiol (Rome); 2011 May; 12(5):319-26. PubMed ID: 21593950
[TBL] [Abstract][Full Text] [Related]
3. Anaemia management in cardio renal disease.
Silverberg DS; Wexler D; Iaina A; Schwartz D
J Ren Care; 2010 May; 36 Suppl 1():86-96. PubMed ID: 20586904
[TBL] [Abstract][Full Text] [Related]
4. Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anaemia.
van Veldhuisen DJ; Dickstein K; Cohen-Solal A; Lok DJ; Wasserman SM; Baker N; Rosser D; Cleland JG; Ponikowski P
Eur Heart J; 2007 Sep; 28(18):2208-16. PubMed ID: 17681958
[TBL] [Abstract][Full Text] [Related]
5. [Current issues in erythropoietin therapy of renal anemia].
Zakar G
Lege Artis Med; 2007 Oct; 17(10):667-73. PubMed ID: 19227596
[TBL] [Abstract][Full Text] [Related]
6. The interaction between heart failure and other heart diseases, renal failure, and anemia.
Silverberg DS; Wexler D; Iaina A; Schwartz D
Semin Nephrol; 2006 Jul; 26(4):296-306. PubMed ID: 16949468
[TBL] [Abstract][Full Text] [Related]
7. Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III, anaemia correction, morbidity-mortality trial.
McMurray JJ; Anand IS; Diaz R; Maggioni AP; O'Connor C; Pfeffer MA; Polu KR; Solomon SD; Sun Y; Swedberg K; Tendera M; van Veldhuisen DJ; Wasserman SM; Young JB;
Eur J Heart Fail; 2009 Aug; 11(8):795-801. PubMed ID: 19633103
[TBL] [Abstract][Full Text] [Related]
8. Erythropoiesis-stimulating agents and heart failure.
Lipšic E; van der Meer P; van Veldhuisen DJ
Cardiovasc Ther; 2011 Aug; 29(4):e52-9. PubMed ID: 20973926
[TBL] [Abstract][Full Text] [Related]
9. The safety and tolerability of darbepoetin alfa in patients with anaemia and symptomatic heart failure.
Klapholz M; Abraham WT; Ghali JK; Ponikowski P; Anker SD; Knusel B; Sun Y; Wasserman SM; van Veldhuisen DJ
Eur J Heart Fail; 2009 Nov; 11(11):1071-7. PubMed ID: 19815661
[TBL] [Abstract][Full Text] [Related]
10. Recognition and treatment of anemia in the setting of heart failure due to systolic left ventricular dysfunction.
Howlett JG
Expert Rev Cardiovasc Ther; 2008 Feb; 6(2):199-208. PubMed ID: 18248274
[TBL] [Abstract][Full Text] [Related]
11. Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure.
Opasich C; Cazzola M; Scelsi L; De Feo S; Bosimini E; Lagioia R; Febo O; Ferrari R; Fucili A; Moratti R; Tramarin R; Tavazzi L
Eur Heart J; 2005 Nov; 26(21):2232-7. PubMed ID: 15987710
[TBL] [Abstract][Full Text] [Related]
12. Anaemia and heart failure: aetiology and treatment.
Klutstein MW; Tzivoni D
Nephrol Dial Transplant; 2005 Jul; 20 Suppl 7():vii7-10. PubMed ID: 16024833
[TBL] [Abstract][Full Text] [Related]
13. Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial.
Ponikowski P; Anker SD; Szachniewicz J; Okonko D; Ledwidge M; Zymlinski R; Ryan E; Wasserman SM; Baker N; Rosser D; Rosen SD; Poole-Wilson PA; Banasiak W; Coats AJ; McDonald K
J Am Coll Cardiol; 2007 Feb; 49(7):753-62. PubMed ID: 17306703
[TBL] [Abstract][Full Text] [Related]
14. Effects of darbepoetin-alpha on quality of life and emotional stress in anemic patients with chronic heart failure.
Kourea K; Parissis JT; Farmakis D; Paraskevaidis I; Panou F; Filippatos G; Kremastinos DT
Eur J Cardiovasc Prev Rehabil; 2008 Jun; 15(3):365-9. PubMed ID: 18525396
[TBL] [Abstract][Full Text] [Related]
15. Anaemia, diabetes and chronic kidney disease: where are we now?
Stevens PE
J Ren Care; 2012 Feb; 38 Suppl 1():67-77. PubMed ID: 22348366
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin treatment in patients with chronic heart failure: a meta-analysis.
van der Meer P; Groenveld HF; Januzzi JL; van Veldhuisen DJ
Heart; 2009 Aug; 95(16):1309-14. PubMed ID: 19168472
[TBL] [Abstract][Full Text] [Related]
17. Effects of darbepoetin alpha on right and left ventricular systolic and diastolic function in anemic patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Parissis JT; Kourea K; Panou F; Farmakis D; Paraskevaidis I; Ikonomidis I; Filippatos G; Kremastinos DT
Am Heart J; 2008 Apr; 155(4):751.e1-7. PubMed ID: 18371487
[TBL] [Abstract][Full Text] [Related]
18. Anemia in chronic heart failure: can we treat? What to treat?
von Haehling S; Anker MS; Jankowska EA; Ponikowski P; Anker SD
Heart Fail Rev; 2012 Mar; 17(2):203-10. PubMed ID: 21979835
[TBL] [Abstract][Full Text] [Related]
19. Future directions in management of anemia in heart failure.
Agarwal AK; Katz SD
Heart Fail Clin; 2010 Jul; 6(3):385-95. PubMed ID: 20630412
[TBL] [Abstract][Full Text] [Related]
20. Anaemia in older people with chronic heart failure: The potential cost.
Man-Fai Sim V; Nam MC; Riley S; Yousef Z; Hurley J; Cheung WY; O'Mahony S
Technol Health Care; 2009; 17(5-6):377-85. PubMed ID: 20051617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
